AGO2 and breast carcinoma: As shown in Appendix Fig. S2B, luciferase-labeled HCC1806 Ago2-KO/AID-Ago2Wt/Ago2∆ breast cancer cells were injected into the fat pads of SCID mice, which were then continuously treated with PBS or IAA for 2 weeks.